Mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine made by activated T cells, macrophages, vascular endothelial cells and fibroblasts.It has potent stimulatory effects on the growth and differentiation of bone marrow progenitor cells that generate granulocytes, monocytes/macrophages, and megakaryocytes.In peripheral tissues, GM-CSF can act on mature leukocytes to promote inflammatory responses.Mouse GM-CSF runs as a 15.5 - 19 kD band in reducing and non-reducing SDS-PAGE analysis.Mouse GM-CSF protein contains 124 amino acid residues.Recombinat mouse GM-CSF (Cat. No. 554586) is supplied as a frozen liquid comprised of 0.22 um sterile-filtered aqueous buffered solution containing bovine serum albumin, with no preservatives.Recombinant mouse GM-CSF is ≥ 95% pure as determined by SDS-PAGE and an absorbance assay based on the Beers-Lambert law.The endotoxin level is ≤ 0.1 ng per µg of mouse GM-CSF, as measured in chromogenic LAL assay.
Purified Rat Anti-Mouse GM-CSF MP1-22E9RUO 0.5mgCat No: 554404
Biotin Rat Anti-Mouse GM-CSF MP1-31G6RUO 0.5mgCat No: 554407
PE Rat Anti-Mouse GM-CSF MP1-22E9RUO 0.1mgCat No: 554406
Mouse GM-CSF ELISA Set RUO 20Cat No: 555167
Resources & Tools | ||||||
---|---|---|---|---|---|---|
SpectrumViewer | Download TDS | Regulatory Document Website |
Store product at -80°C prior to use or for long term storage of stock solutions.Rapidly thaw and quick-spin product prior to use.Avoid multiple freeze-thaws of product.This preparation contains no preservatives, thus it should be handled under aseptic conditions.
Upon initial thawing, recombinant mouse GM-CSF (Cat. No. 554586) should be aliquoted into polypropylene microtubes and frozen at -80°C for future use.Alternatively, the product can be diluted in sterile neutral buffer containing not less than 0.5 - 10 mg/mL carrier protein, such as human or bovine albumin, aliquoted and stored at -80°C.For in vitro biological assay use, carrier protein concentrations of 0.5 - 1 mg/mL are recommended.For use as an ELISA standard, carrier-protein concentrations of 5 - 10 mg/mL are recommended.Failure to add carrier protein or store at indicated temperatures may result in a loss of activity. This product should not be diluted to less than 5 μg/mL for long term storage.Carrier proteins should be pre-screened for possible effects in each investigator"s experimental system.Carrier proteins may have an undesired influence on experimental results due to toxicity, high endotoxin levels or possible blocking activity.
ELISA Standard: Recombinant mouse GM-CSF (Cat. No. 554586) can be useful as a quantitative standard for measuring mouse GM-CSF protein levels using sandwich ELISA with the purified MP1-22E9 antibody (Cat. No. 554404) as a capture antibody and biotinylated MP1-31G6 antibody (Cat. No. 554407) as the detection antibody.To obtain linear standard curves, investigators may want to consider using doubling dilutions of recombinant mouse GM-CSF standard from 2,000 - 15 pg/mL to be included in each ELISA plate.For measuring mouse GM-CSF in serum or plasma, investigators are highly encouraged to use the BD OptEIA™ Mouse GM-CSF ELISA Set (Cat. No. 555167).
Bioassay: Investigators are advised that the Bioassay application is not routinely tested for this material and are highly encouraged to both titrate this material and include appropriate controls in relevant experiments.An activity range of 0.25 - 5.0 x 10^9 units/mg, encompassing an
ED50= 2 - 35 pg/mL, has previously been reported using MC/9 as indicator cells for proliferation, with a unit defined as the amount of material needed to stimulate a half-maximal response at cytokine saturation.
Blocking: Recombinant mouse GM-CSF (Cat. No. 554586) can be useful as a blocking control for flow cytometric analysis when used with PE-conjugated MP1-22E9 antibody (Cat. No. 554406).Investigators are advised that the blocking application is not routinely tested for this material.Intracellular cytokine staining techniques and the use of blocking controls are described in detail by C. Prussin and D. Metcalfe.
BD是世界上最大的生产和销售医疗设备、医疗系统和试剂的医疗技术公司之一。致力于提高全世界人类的健康水平。BD专注于改进药物治疗,提高传染性疾病诊断的质量和速度,推进新型药物和疫苗的研究与发现。公司于1897年在纽约成立,总部位于美国新泽西州的富兰克林湖,业务可分为BD医疗、BD诊断、BD生物科学三大类,生产销售包括医用耗材、实验室仪器、抗体、试剂、诊断等产品。